Brazil Breaks Patent On Merck's AIDS Drug

Law360, New York (May 4, 2007, 12:00 AM EDT) -- Brazil’s president has signed a compulsory license that overrides Merck & Co. Inc.’s patent on HIV/AIDS drug Efavirenz so that the country can import a generic version of the drug from India.

The move by President Luiz Inacio Lula da Silva on Friday marked the first time Brazil broke a patent to obtain more affordable drugs for its AIDS prevention program. Thailand has taken a similar step, and countries like Canada and Italy have exercised a provision in World Trade Organization rules to defy drug patents...
To view the full article, register now.